Chief Financial Officer
Thu, Apr 23, 2026
Apr 23
exercised or converted securities in PCRX
12,941 shares @ $16.45
Increased holdings by +12.30%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
PCRXPacira BioSciences, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+2.95%
1M-7.55%
3M-1.79%
6M—
1Y—